{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:33:06Z","timestamp":1781839986228,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00277-018-3471-x","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T22:30:28Z","timestamp":1533853828000},"page":"2411-2416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience"],"prefix":"10.1007","volume":"97","author":[{"given":"Francesca","family":"De Felice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Grapulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna Maria","family":"D\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pulsoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Musio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Tombolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"issue":"21","key":"3471_CR1","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR (2009) Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 113(21):5064\u20135073","journal-title":"Blood"},{"key":"3471_CR2","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition)","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffa ES, Pileri SA, Stein H, Thiele J (eds) (2017) WHO classification of tumours of haematopoietic and lymphoid tissues (revised 4th edition). lARC, Lyon"},{"issue":"3","key":"3471_CR3","doi-asserted-by":"publisher","first-page":"329.e1\u201313","DOI":"10.1016\/j.jaad.2013.06.011","volume":"69","author":"AL Su\u00e1rez","year":"2013","unstructured":"Su\u00e1rez AL, Pulitzer M, Horwitz S, Moskowitz A, Querfeld C, Myskowski PL (2013) Primary cutaneous B-cell lymphomas: part I. Clinical features, diagnosis, and classification. J Am Acad Dermatol 69(3):329.e1\u201313","journal-title":"J Am Acad Dermatol"},{"key":"3471_CR4","unstructured":"National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Primary cutaneous B-cell lymphomas, version 2.2018. Available at: \n                    http:\/\/www.nccn.org\n                    \n                  . Accessed 1 Feb 2018"},{"issue":"5","key":"3471_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2340\/00015555-1112","volume":"91","author":"C Hallermann","year":"2011","unstructured":"Hallermann C, Niermann C, Fischer RJ, Schulze HJ (2011) Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study. Acta Derm Venereol 91(5):521\u2013525","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"3471_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.ijrobp.2013.07.019","volume":"87","author":"SN Hamilton","year":"2013","unstructured":"Hamilton SN, Wai ES, Tan K, Alexander C, Gascoyne RD, Connors JM (2013) Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience. Int J Radiat Oncol Biol Phys 87(4):719\u2013725","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3471_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00277-010-1083-1","volume":"90","author":"M Mian","year":"2011","unstructured":"Mian M, Marcheselli L, Luminari S, Federico M, Cantonetti M, Sarris AH, Rossi A, Rambaldi A, Frontani M, Devizzi L, Gianni AM, Busetto M, Berti E, Martinelli G, Tsang RW, Ferreri AJ, Pinotti G, Pogliani E, Zucca E, Cortelazzo S (2011) CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11). Ann Hematol 90(4):401\u2013408","journal-title":"Ann Hematol"},{"issue":"12","key":"3471_CR8","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1001\/archderm.143.12.1520","volume":"143","author":"NJ Senff","year":"2007","unstructured":"Senff NJ, Hoefnagel JJ, Neelis KJ, Vermeer MH, Noordijk EM, Willemze R, Dutch Cutaneous Lymphoma Group (2007) Results of radiotherapy in 153 primary cutaneous B-cell lymphomas classified according to the WHO-EORTC classification. Arch Dermatol 143(12):1520\u20131526","journal-title":"Arch Dermatol"},{"issue":"9","key":"3471_CR9","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","volume":"24","author":"PL Zinzani","year":"2006","unstructured":"Zinzani PL, Quaglino P, Pimpinelli N, Berti E, Baliva G, Rupoli S, Martelli M, Alaibac M, Borroni G, Chimenti S, Alterini R, Alinari L, Fierro MT, Cappello N, Pileri A, Soligo D, Paulli M, Pileri S, Santucci M, Bernengo MG, Italian Study Group for Cutaneous Lymphomas (2006) Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol 24(9):1376\u20131382","journal-title":"J Clin Oncol"},{"issue":"10","key":"3471_CR10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1634\/theoncologist.2015-0175","volume":"20","author":"B Haverkos","year":"2015","unstructured":"Haverkos B, Tyler K, Gru AA, Winardi FK, Frederickson J, Hastings J, Elkins C, Zhang X, Xu-Welliver M, Wong HK, Porcu P (2015) Primary cutaneous B-cell lymphoma: management and patterns of recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. Oncologist 20(10):1161\u20131166","journal-title":"Oncologist"},{"issue":"1","key":"3471_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/DAD.0b013e31815f9841","volume":"30","author":"Z Khamaysi","year":"2008","unstructured":"Khamaysi Z, Ben-Arieh Y, Izhak OB, Epelbaum R, Dann EJ, Bergman R (2008) The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center. Am J Dermatopathol 30(1):37\u201344","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"3471_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s12185-014-1728-2","volume":"101","author":"MJ Kim","year":"2015","unstructured":"Kim MJ, Hong ME, Maeng CH, Jung HA, Hong JY, Choi MK, Kim SJ, Ko YH, Kim WS (2015) Clinical features and treatment outcomes of primary cutaneous B-cell lymphoma: a single-center analysis in South Korea. Int J Hematol 101(3):273\u2013278","journal-title":"Int J Hematol"},{"issue":"7","key":"3471_CR13","doi-asserted-by":"publisher","first-page":"888","DOI":"10.2340\/00015555-2404","volume":"96","author":"WJ Lee","year":"2016","unstructured":"Lee WJ, Lee SH, Moon IJ, Won CH, Chang SE, Choi JH, Park CS, Suh C, Lee MW (2016) Relative frequency, clinical features, and survival outcomes of 395 patients with cutaneous lymphoma in Korea: a subgroup analysis per 10-year period. Acta Derm Venereol 96(7):888\u2013893","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"3471_CR14","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1002\/cam4.865","volume":"5","author":"M Lucioni","year":"2016","unstructured":"Lucioni M, Berti E, Arcaini L, Croci GA, Maffi A, Klersy C, Goteri G, Tomasini C, Quaglino P, Riboni R, Arra M, Dallera E, Grandi V, Alaibac M, Ramponi A, Rattotti S, Cabras MG, Franceschetti S, Fraternali-Orcioni G, Zerbinati N, Onida F, Ascani S, Fierro MT, Rupoli S, Gambacorta M, Zinzani PL, Pimpinelli N, Santucci M, Paulli M (2016) Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: comparison with current classification and definition of prognostic markers. Cancer Med 5(10):2740\u20132755","journal-title":"Cancer Med"},{"issue":"12","key":"3471_CR15","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1111\/ijd.12970","volume":"54","author":"LM Nudelmann","year":"2015","unstructured":"Nudelmann LM, Bonamigo RR (2015) Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience. Int J Dermatol 54(12):e512\u2013e520","journal-title":"Int J Dermatol"},{"key":"3471_CR16","unstructured":"Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 4.0 2009, Available at: \n                    http:\/\/ctep.cancer.gov\n                    \n                  . Accessed 1 Feb 2018"},{"issue":"1","key":"3471_CR17","first-page":"5","volume":"4","author":"BD Cheson","year":"2015","unstructured":"Cheson BD (2015) Staging and response assessment in lymphomas: the new Lugano classification. Chin Clin Oncol 4(1):5","journal-title":"Chin Clin Oncol"},{"issue":"4","key":"3471_CR18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper M, Smith TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17(4):343\u2013346","journal-title":"Control Clin Trials"},{"key":"3471_CR19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1182\/blood-2006-10-054601","volume":"110","author":"YH Kim","year":"2007","unstructured":"Kim YH, Willemze R, Ni P, for the ISCL and the EORTC et al (2007) TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110:479\u2013484","journal-title":"Blood"},{"issue":"12","key":"3471_CR20","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1097\/00000478-200312000-00006","volume":"27","author":"JR Goodlad","year":"2003","unstructured":"Goodlad JR, Krajewski AS, Batstone PJ, McKay P, White JM, Benton EC, Kavanagh GM, Lucraft HH (2003) Scotland and Newcastle Lymphoma Group. Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes. Am J Surg Pathol 27(12):1538\u20131545","journal-title":"Am J Surg Pathol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-018-3471-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-018-3471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T23:05:42Z","timestamp":1565391942000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-018-3471-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3471"],"URL":"https:\/\/doi.org\/10.1007\/s00277-018-3471-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]},"assertion":[{"value":"24 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author Francesca De Felice declares that she has no conflict of interest. Author Lavinia Grapulin declares that she has no conflict of interest. Author Alessandra Pieroni declares that she has no conflict of interest. Author Francesca Salerno declares that she has no conflict of interest. Author Gianna Maria D\u2019Elia declares that she has no conflict of interest. Author Alessandro Pulsoni declares that he has no conflict of interest. Author Daniela Musio declares that she has no conflict of interest. Author Vincenzo Tombolini declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}